A diagnosis records what you have. It usually doesn't record what was happening when it started.

This practice builds that page.

Take one sheet of paper. Draw a line across the middle. Mark the month your symptoms first appeared, as best you can remember. Then mark the month you were diagnosed. The gap between those two marks is often longer than people expect.

Above the line, write what your body was doing. The first change you noticed, even if it seemed too small to mention. Sleep. Appetite. Energy. Pain. Digestion. Skin.

Below the line, write what your life was doing during the same months. A move, a loss, a new job, a caregiving role, a relationship ending, a stretch of short nights. Keep it factual. You are not looking for a cause.

Then add one more row at the bottom: family. Anyone related to you with a similar condition, or with anything the family called "nothing." Dry skin. A nervous stomach. Bad knees. Write the family's words, not a diagnosis.

Look at the page once. Don't draw conclusions from it.

Bring it to the clinician who manages your condition and ask one question:

Is there anything on this page that should be in my chart?

This practice is reflective, not medical advice. Do not stop or change prescribed treatment because of what you notice. Bring the page to your clinician.

It goes with last week’s essay, The Diagnosis Was Correct. The Story Was Incomplete.

Practices here are small, specific, and meant to be done, not admired. Subscribing is free, and it's how the next one finds you.

If someone you love is carrying a diagnosis without the story around it, send this to them.

Share

What did you write below the line? Tell me in the comments. I read them.

Leave a comment

Dr Shiv Kumar Goel is an internal medicine and functional medicine physician and founder of Prime Vitality Care in San Antonio. Across 25 years in hospitals, intensive care, and functional medicine, he has studied the gap between what medicine can measure and what patients actually live through. He writes Healing the Split and is the author of the forthcoming book The Unread Life.

This case is a composite drawn from clinical encounters over many years. Names, ages, occupations, timelines, and identifying circumstances have been changed. No individual patient is depicted. The clinical pattern has been preserved.

The intake form has a line for family history.

Most people fill it in the way they fill in a parking permit. Diabetes, heart disease, cancer. The big three. Anything smaller feels like it would waste the doctor's time.

His father's skin didn't make his list.

In the third visit, while we were talking about something else, he mentioned that his father's forearms had always been covered. Long sleeves, even in summer.

"Dry skin," he said. "Not arthritis. Unrelated."

He had psoriatic arthritis. His father had psoriasis. The two conditions share a genetic neighborhood, and they cluster in families.

I asked about anyone else.

A pause. Then an uncle. Rheumatoid arthritis, hands that bent slowly over the years. He'd kept working and called it nothing.

Three men. Two generations. Nobody had ever written them on the same page.

The genetics mattered on their own. His disease had a family history, and it belonged in his chart.

But the word he chose mattered too.

Unrelated.

It wasn't a lie. It was a family habit. In his family, you described what the body was doing in the smallest possible terms, so that it would never become a reason to stop. His father had worked through almost two years of fever and never named it. His uncle had worked with deformed hands and called it nothing.

He had been taking his biologic perfectly for years while his flares climbed. He described that to me in the same flat, logistical voice. Doses, dates, swollen fingers. No complaint.

The diagnosis in his chart was correct. The family history section was the part that was wrong.

We fixed the chart first. Then we started asking what else had been filed under unrelated.

That question took longer than the visit.

This case note is the companion to Saturday’s essay, The Diagnosis Was Correct. The Story Was Incomplete.

Case Notes are short stories from the exam room, the moments that change a visit. Subscribing is free, and it's how the next one finds you.

If someone you love fills in family history with "nothing important," send this to them.

Share

What does your family call "nothing"? Tell me in the comments. I read them.

Leave a comment

Dr Shiv Kumar Goel is an internal medicine and functional medicine physician and founder of Prime Vitality Care in San Antonio. Across 25 years in hospitals, intensive care, and functional medicine, he has studied the gap between what medicine can measure and what patients actually live through. He writes Healing the Split and is the author of the forthcoming book The Unread Life.

This case is a composite drawn from clinical encounters over many years. Names, ages, occupations, timelines, and identifying circumstances have been changed. No individual patient is depicted. The clinical pattern has been preserved.

He mentioned his father's skin in the third visit, almost as an apology for taking up time.

"Dry skin. Not arthritis. Unrelated."

He said the last word quickly, the way people do when they've already decided something doesn't count.

His own diagnosis was psoriatic arthritis. He'd received it in his mid-thirties, and it was correct. A rheumatologist had made it carefully and started a biologic. He took it exactly as prescribed.

I want to be clear about that part before anything else.

Nothing about his diagnosis was wrong. Psoriatic arthritis is a real inflammatory disease that can damage joints permanently. Biologic medicines changed what that disease does to people. That's evidence doing exactly what it should.

So this is not an essay about a missed diagnosis.

It's about what a correct one could not explain.

He came to me because the flares were getting worse. Eighteen months of rising disease activity, on a medication he took perfectly. His rheumatologist had suggested stress management.

He heard what most patients hear in that sentence. The problem is you.

I understood why the advice was given. I also understood why it landed badly. It pointed at something real and then left him alone with it.

Here's what the guidelines say to do when psoriatic arthritis stays active on a biologic. The 2023 European recommendations set the target as remission or low disease activity, with regular reassessment and adjustment. If a patient doesn't respond adequately, switching to another agent should be considered. The same recommendations tell clinicians to weigh comorbidities like obesity, metabolic syndrome, cardiovascular disease, and depression.

That is the population answer, and it's a good one. That conversation belonged with his rheumatologist, and nothing I did replaced it.

But the guideline could not know what I learned in the third visit.

When I asked whether anyone in his family had inflammatory or autoimmune problems, he mentioned the psoriasis. Then he paused. Then he mentioned an uncle with rheumatoid arthritis. The uncle had kept working with hands that slowly bent out of shape, and had called it nothing.

Nobody had ever put those men in the same sentence as his diagnosis.

Some of that is plain biology. Psoriatic disease runs in families. In one study of the families of 100 people with psoriatic arthritis, 7.6 percent of their parents, siblings and children had the arthritis too. That's about 30 times the rate you'd expect in the general population. Another 15 percent had psoriasis. His father's "dry skin" wasn't unrelated. It was part of his history, and it belonged in his chart.

The rest of the pattern was harder to name.

His father came to this country at twenty-two with tools and a conviction that a man who stopped was a man who failed. He built a small construction business over twenty-five years. For almost two of those years, he ran a fever and told no one but his wife. He kept working. The fever eventually went away, and nobody ever learned what it had been.

His son grew up inside that example. Nobody had to say the rule out loud.

You don't stop.

I asked him a question I ask a lot of people who are running on that rule. When did the work stop feeling like something you were doing and start feeling like something that was doing you?

The question opened a story he hadn't connected to his joints. Two years earlier, his company had been acquired. His hours hadn't exploded. What changed was quieter. The meaning of the work had been replaced by someone else's metrics. He kept performing at the same level. Then his flares began to climb.

Now I have to be careful, because this is exactly where wellness writing goes wrong.

Nothing here says stress gave him psoriatic arthritis. His genes and his immune system did that. I can't prove the acquisition caused a single flare. Nobody can prove that from one life.

What the evidence does support is narrower. In a large 2026 survey of people with psoriasis, stress was the trigger reported most often, by just over half of them. That's self-report, and it's about the skin disease, not the arthritis. Laboratory work points toward one possible mechanism. In a 2012 study, people living with a long-term threatening stressor had immune cells that responded less to cortisol's anti-inflammatory signal, and that reduced sensitivity predicted more inflammatory output after exposure to a cold virus. That was a cold model, not autoimmune disease. It's a direction, not a verdict.

Sleep is on firmer ground. A 2016 meta-analysis of 72 studies and more than 50,000 people linked disturbed sleep with higher levels of two inflammatory markers, CRP and IL-6. His sleep had been poor for a long time, and he called it normal.

So the clinical question changed.

It was no longer only whether the diagnosis was right. It was. The better question was what, in this particular life, kept supplying the fire the medication was trying to put out.

We didn't tell him to work less in some vague way. He had a family and a business. We started with sleep, because it was measurable and because he could protect it. We talked about the work question honestly, without pretending he could walk away from it. And he kept every appointment with his rheumatologist.

Over about eight months, his flares came less often and hurt less when they came. I can't separate what the sleep did from what time did, or from what the medication was doing all along. I won't pretend otherwise.

What I can tell you is what changed in how he read them.

He stopped treating a flare as proof that his body was a defective tool. He started treating it as information about what the week had cost.

One afternoon he mentioned, almost in passing, that his teenage son had woken up sick. He'd told him, "Take the day. The work will wait."

He said it like a scheduling detail. His face said something else.

The diagnosis was correct from the beginning. It named his disease. It told his doctors which medicine to use, and that medicine protected his joints.

It just hadn't met his father yet.

I write Healing the Split for people whose diagnosis is right and whose recovery still feels incomplete. Subscribing is free, and it's how the next essay finds you.

If someone you love has a correct diagnosis and an unfinished story, send this to them.

Share

What did no one ask you when you got your diagnosis? Tell me in the comments. I read them.

Leave a comment

This essay uses a composite drawn from clinical encounters over many years. Names, ages, occupations, timelines, and identifying circumstances have been changed. No individual patient is depicted. It is not medical advice. If your condition is active on treatment, bring that to the clinician managing it.

Sources: Gossec L, et al. EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update. Annals of the Rheumatic Diseases, 2024. Chandran V, et al. Familial aggregation of psoriatic arthritis. Annals of the Rheumatic Diseases, 2009. PSODEEP1 study: psoriasis triggers and disease activity, Acta Dermato-Venereologica, 2026. Cohen S, et al. Chronic stress, glucocorticoid receptor resistance, inflammation, and disease risk. PNAS, 2012. Irwin MR, Olmstead R, Carroll JE. Sleep disturbance, sleep duration, and inflammation. Biological Psychiatry, 2016.

Dr Shiv Kumar Goel is an internal medicine and functional medicine physician and founder of Prime Vitality Care in San Antonio. Across 25 years in hospitals, intensive care, and functional medicine, he has studied the gap between what medicine can measure and what patients actually live through. He writes Healing the Split and is the author of the forthcoming book The Unread Life.

Choose one capacity people rely on in you.

It may be endurance, precision, calm, physical strength, availability, or the ability to finish difficult work.

Do not decide that the capacity is unhealthy.

For one week, record three moments when you use it. Keep the observations concrete.

First, write what the moment actually required.

Second, write how much of your capacity you used.

Third, write what happened after the demand ended.

Did the strength release when the work was finished?

Did you keep applying it because another task genuinely required it?

Or did the effort continue after its purpose had disappeared?

At the end of the week, review the three moments. Ask one question:

Was I using this strength, or was I proving that I still had it?

The distinction will not always be clear. That uncertainty is useful. The purpose is not to become less capable. It is to notice whether capacity still has direction.

If the pattern involves prescribed exercise, rehabilitation, medication, or treatment, do not change the plan from a newsletter exercise. Bring the observation to the clinician responsible for that care.

It goes with last week’s essay, What I Got Wrong About Strength.

Practices here are small, specific, and meant to be done, not admired. Subscribing is free, and it's how the next one finds you.

If someone you know is praised for how much they carry, send this to them.

Share

Were you using your strength, or proving you still had it? Tell me in the comments. I read them.

Leave a comment

Dr Shiv Kumar Goel is an internal medicine and functional medicine physician and founder of Prime Vitality Care in San Antonio. Across 25 years in hospitals, intensive care, and functional medicine, he has studied the gap between what medicine can measure and what patients actually live through. He writes Healing the Split and is the author of the forthcoming book The Unread Life.

At 5:12 on a Tuesday in late October, Nora Castillo had the rice on. The chicken was resting under foil, and three plates were warming in an oven that didn’t need to be on.

Next door, the Aguilar boys were taping plastic ghosts to their front window. One was upside down. The smaller boy kept pressing its face to the glass …

Read more

The pose had worked in practice.

Onstage, my middle back tightened. My traps began to cramp. They had already been inflamed, and I could not open my back far enough to present the shape I had rehearsed.

The failure was small enough that most people would have missed it.

I did not.

Bodybuilding is built from details that become visible only after hundreds of repetitions. A shoulder placed a fraction too high. A waist not held tightly enough. A back that opens too late. Two minutes can reveal months of preparation.

Those two minutes revealed something else.

I believed the failed pose cost me first place in Open. I won Masters and placed third in Open. Both facts remained true at once: I had achieved something meaningful, and I could see the result I might have reached.

That was the familiar question.

What could I have done better?

The unfamiliar question arrived beside it.

What was I asking all this strength to prove?

The question did not make the competition a mistake. It did not turn discipline into disease. It did not transform a physical cramp into a coded message.

My traps cramped because they were under physical demand.

The interruption simply removed my ability to perform the answer I had prepared.

I could not open my back.

For a moment, I could not hide behind the finished shape either.

Strength had given me structure, patience, and a body capable of more than I once expected at 45. But the same evidence could not tell me whether every additional demand remained useful.

Force can be measured.

Purpose cannot.

The stage showed what I had built. The failed pose made me ask what the building was now serving.

That question stayed longer than the cramp.

This field note is the companion to Tuesday's essay, What I Got Wrong About Strength.

Field Notes are short scenes from my own life in medicine and training. Subscribing is free, and it's how the next one finds you.

If someone you love is still proving they can carry more, send this to them.

Share

What are you still asking your strength to prove? Tell me in the comments. I read them.

Leave a comment

Dr Shiv Kumar Goel is an internal medicine and functional medicine physician and founder of Prime Vitality Care in San Antonio. Across 25 years in hospitals, intensive care, and functional medicine, he has studied the gap between what medicine can measure and what patients actually live through. He writes Healing the Split and is the author of the forthcoming book The Unread Life.

My middle back tightened before I finished the pose.

Then my traps began to cramp.

They had already been inflamed. Under the stage lights, they would not open the way I had practiced. During the two minutes for which I had trained for months, my body could not make the shape I had taught it to make.

I knew what the failed pose could cost.

I believed it kept me from winning the Open division.

I won Masters and placed third in Open. I was proud of that result. I still believed the cramp had cost me first place.

But something else mattered more during those two minutes.

The one thing I had focused on most had somehow lost its purpose.

I was 45 when I entered the bodybuilding competition.

I had practiced medicine for two decades. I had ordered thousands of laboratory panels. I had advised patients about exercise, nutrition, sleep, hormones, and recovery.

None of that made me the expert backstage.

I was there to be judged on what the body could show.

Muscularity. Symmetry. Leanness. Presentation.

The visible result of months spent training, eating with precision, protecting recovery, and repeating the work when progress appeared absent.

I respected that work then.

I respect it now.

Resistance training is real medicine. The 2026 American College of Sports Medicine position stand synthesized 137 systematic reviews involving more than 30,000 participants. Resistance training improved strength, hypertrophy, power, balance, gait speed, and several measures of physical function.

The same position stand made another point worth protecting. Programs should fit a person's goals and enjoyment. Complexity matters less than a plan a person can sustain.

Bodybuilding placed me inside the prescription I had given others.

I learned how slowly a body can change after 40.

I learned that effort does not guarantee a result on schedule. A flawless week does not always produce a visible improvement. One mistake does not erase months of work.

That experience changed how I listened to patients.

When someone told me they had followed a plan without seeing progress, I heard more than the stalled number. I heard the early mornings, the declined meals, the doubt, and the decision to continue.

For a long time, I believed that was the competition’s most important lesson.

Strength meant showing up.

It meant returning when the result did not reward you. It meant accepting that biology does not move according to motivation.

That remains true.

It was also incomplete.

At first, the competition gave my discipline a clear direction. It asked me to test what was possible at an age when many people begin accepting less from their bodies.

Training gave me structure.

Preparation made me more patient.

The stage required me to enter a room where I was not the authority.

Those were real gifts.

But a serious pursuit can change without announcing that it has changed.

A goal may begin by serving the person. Somewhere along the way, the person may begin serving the goal.

Food served the stage.

Sleep served the stage.

Recovery served the stage.

Even the mirror became less a place to see myself than another instrument of correction.

I kept chasing the next improvement.

More definition. Better symmetry. Greater control. Fewer mistakes.

Perfection kept moving farther away. I kept assuming the answer was greater precision.

That is what I began to see during those two minutes.

My middle back was tight. My traps were cramping. I could not open the pose I had practiced most.

Part of me immediately calculated the consequence.

I might have lost first place.

But another part of me recognized something harder.

The constant chasing had begun producing the opposite of what I believed I was building.

I had called it strength because I could tolerate more.

More training. More hunger. More precision. More pressure.

But carrying too much was not strength.

It was making me too weak to admit what the carrying cost.

That distinction reaches beyond bodybuilding.

Medicine can measure strength through force, muscle mass, mobility, and function. Those measurements matter. They help us understand whether someone can climb stairs, recover balance, lift an object, or remain physically independent.

They cannot tell us what that strength is serving.

One person trains because strength expands freedom.

Another trains because the next achievement has become proof that the previous one was not enough.

The exercise may look identical.

Its purpose may not be.

I had treated strength as the capacity to carry more.

I had not asked whether carrying more was always the right use of that capacity.

I had not asked when the pursuit had stopped training my system and started feeding my ego.

That question does not make ambition dangerous.

It does not make discipline a symptom.

It does not mean the cramp contained a message or that biography explains every physical event. My back and traps had been placed under prolonged physical demand. The cramp was physical.

But physical events happen inside lives.

The cramp did not explain my life.

It interrupted the performance long enough for me to question it.

What was all this strength serving now?

My biology had not turned against me.

It had followed the plan.

It followed the preparation, the repetitions, and every additional demand. It adapted to the biography I believed I was building correctly.

Until I could no longer ignore the cost.

That is not betrayal.

It is the limit of adaptation.

The mistake was mine. I had confused my body’s capacity to adjust with evidence that every demand deserved to continue.

Since when had strength meant carrying everything?

Strength is capacity used when capacity is needed.

It is not diminished by admitting a limit. Sometimes that admission is what preserves the capacity we still have.

Discipline remains valuable.

It brought me to that stage. It taught me patience. It changed how I speak to patients whose bodies have not responded on schedule.

But discipline needs direction.

Otherwise, it becomes excellent execution in service of a purpose that has already disappeared.

The trophy still matters to me.

It marks the preparation, the hunger, and the decision to enter a room where I was not the expert.

It also marks the limit of what performance can establish.

I went onstage to present the most finished version of my body.

My back would not open.

I lost the pose I had practiced most.

Perhaps it cost me first place in Open. That still matters.

But something more lasting happened during those two minutes.

The pursuit no longer got to define strength by how much I could endure.

I had built a body capable of carrying more.

I began asking whether everything I carried still deserved my strength.

Sources: American College of Sports Medicine, Resistance Training Prescription for Muscle Function, Hypertrophy, and Physical Performance in Healthy Adults: An Overview of Reviews. Medicine & Science in Sports & Exercise, 2026.

I write Healing the Split for people who are strong in every way that shows and tired in ways that don't. Subscribing is free, and it's how the next essay finds you.

If someone you love keeps proving they can carry more, send this to them.

Share

What are you still carrying that no longer deserves your strength? Tell me in the comments. I read them.

Leave a comment

Dr Shiv Kumar Goel is an internal medicine and functional medicine physician and founder of Prime Vitality Care in San Antonio. Across 25 years in hospitals, intensive care, and functional medicine, he has studied the gap between what medicine can measure and what patients actually live through. He writes Healing the Split and is the author of the forthcoming book The Unread Life.

Most health plans count outcomes. Weight. Sleep duration. Glucose. Steps. Symptoms. Medication adherence.

This practice counts the work.

Take one sheet of paper. Write down everything your health currently asks you to do during an ordinary week. Include appointments, refills, meal preparation, food rules, exercise, supplements, devices, symptom tracking, insurance calls, reading, and the private work of worrying about whether you are doing any of it correctly.

Do not organize the list yet.

Read it once as though it belonged to someone you cared about. Notice the total demand before deciding whether any single item is useful.

Beside each task, write one word: helps, unclear, or costs.

“Helps” means you can identify what the task changes. “Unclear” means it entered the plan but no one defined how success would be measured. “Costs” does not mean the task is medically wrong. It means the physical, financial, cognitive, or emotional burden is now substantial.

Then circle one item marked “unclear.”

Do not stop medication or prescribed treatment on your own. Bring that item to the clinician responsible for it and ask three questions.

What specific problem is this addressing?

How will we know whether it is working?

What would allow us to reduce or stop it?

The purpose is not to build a smaller plan for appearance’s sake. The purpose is to make every demand earn its place.

Return to the page one week later. Add what the plan has displaced. Sleep. Meals with other people. Money. Unstructured time. Exercise you enjoy. Work with your hands. A morning that belongs to nobody else.

That second list is clinical information.

Your physician may never see it on a laboratory report. Bring it anyway.

This practice is for reviewing treatment burden with your clinician. It is not a recommendation to stop prescribed medication or treatment.

It goes with last week’s essay, The Patient Who Was Excellent at Being Unwell.

Practices here are small, specific, and meant to be done, not admired. Subscribing is free, and it's how the next one finds you.

If someone you love has a health plan that has become a second job, send this to them.

Share

Which word showed up most on your list: helps, unclear, or costs? Tell me in the comments. I read them.

Leave a comment

Dr Shiv Kumar Goel is an internal medicine and functional medicine physician and founder of Prime Vitality Care in San Antonio. Across 25 years in hospitals, intensive care, and functional medicine, he has studied the gap between what medicine can measure and what patients actually live through. He writes Healing the Split and is the author of the forthcoming book The Unread Life.

This case is a composite drawn from clinical encounters over many years. Names, ages, occupations, timelines, and identifying circumstances have been changed. No individual patient is depicted. The clinical pattern has been preserved.

She arrived with five years of records arranged in chronological order.

Her routine blood work had repeatedly been called normal. The symptoms had not followed the report. Sleep remained broken. Fatigue survived the weekend. Pain moved without settling into a diagnosis.

She had already done the usual rounds.

Primary care had ruled out obvious disease. A specialist had reviewed one part of the picture. A functional clinic had ordered a wider panel and built a large supplement protocol around the findings.

She had followed all of it.

That was the first fact I almost misunderstood.

Physicians are trained to notice nonadherence. We ask whether the patient filled the prescription, changed the diet, attended therapy, or used the device. When the patient does everything asked, we tend to move on.

Adherence reassures us.

Her adherence should not have.

The plan required food tracking, supplement timing, exercise, recovery work, repeated testing, sleep monitoring, and several daily practices. Each part had a rationale. Together, they occupied the remaining space in a life already built around responsibility.

She had not failed treatment.

Treatment had become another environment in which she could prove she needed nothing.

I asked what had disappeared from her life during the years she had been managing her health.

She first answered with tasks she had stopped because of fatigue. Then she named the quieter losses. Unmeasured time. Work done with her hands. The ability to eat without evaluating the meal. A morning that did not begin with a score.

Those losses were not side notes. They changed how I read the case.

The relevant clinical question was no longer whether each recommendation could be defended. Most of them could.

The question was whether their combined workload exceeded her biological and practical capacity.

The concept is established in minimally disruptive medicine. Treatment adds work. Patients have finite capacity. When the work of care exceeds that capacity, a theoretically correct plan can become unlivable.

Her response had been to create more capacity through effort.

That response had protected her for years. It also concealed the point at which adaptation became cost.

We simplified.

We kept the interventions with a clear purpose. We removed what had accumulated without changing the ground. We stopped treating every measurable variation as an instruction. We tracked sleep, recovery, function, and whether parts of her life began returning.

The goal was not fewer interventions as an ideology.

The goal was a plan that left enough person to recover.

Later, she told me she had begun making things again. She did not present this as a health outcome. It was not in the laboratory portal.

It was still one of the clearest signs that the plan finally fit the subject.

This case note is the companion to Saturday’s essay, The Patient Who Was Excellent at Being Unwell.

Case Notes are short stories from the exam room, the moments that change a visit. Subscribing is free, and it's how the next one finds you.

If someone you love is working harder at getting well than at living, send this to them.

Share

What has your health plan quietly pushed out of your week? Tell me in the comments. I read them.

Leave a comment

Dr Shiv Kumar Goel is an internal medicine and functional medicine physician and founder of Prime Vitality Care in San Antonio. Across 25 years in hospitals, intensive care, and functional medicine, he has studied the gap between what medicine can measure and what patients actually live through. He writes Healing the Split and is the author of the forthcoming book The Unread Life.

She placed a manila folder on the desk before she sat down.

The reports were separated by year. The medications were listed by dose. The supplements had their own page, including when she took them and whether they needed food.

She had tracked her meals to the gram. She had tracked her sleep on two devices. She had completed the breathing program, bought the cold-plunge tub, and stayed with the elimination diet longer than anyone had asked.

She was not careless with her health.

She was excellent at being unwell.

That sentence may sound cruel. I mean the opposite.

She had become exceptionally skilled at performing every task illness and healthcare placed before her. She arrived prepared. She remembered dates. She followed instructions. She did not miss appointments or exaggerate symptoms.

Her doctors called her compliant.

She was also exhausted, waking through the night, hurting in places that changed, and losing contact with the person she remembered being.

Nothing in the folder explained that last part.

Medicine has a word for patients who follow the plan: adherent. We usually mean it as praise. Medication taken correctly. Appointments kept. Dietary instructions followed. Monitoring completed.

Those things matter. A treatment cannot help if it is never used.

But adherence answers only one question. Did the patient carry out the plan?

It does not answer whether the plan fit the patient. It does not tell us what carrying it out required. It does not tell us what had to disappear from her life so the plan could remain intact.

That is where this patient had been missed.

She had visited conventional physicians first. Her routine laboratory work was reassuring. Her thyroid was within range. Her glucose did not announce diabetes. Her blood count did not provide a clean explanation for the fatigue.

She was told to improve her sleep and reduce stress.

The advice was not wrong. It was too small.

She then entered the wellness world, where the same suffering produced the opposite conclusion. Instead of nothing being wrong, almost everything became a target. More testing. More flagged values. More supplements. More rules about food, light, temperature, timing, exercise, and recovery.

Some of the biology behind those recommendations was legitimate. Circadian timing matters. Nutrition matters. Movement matters. Breathing can change autonomic state.

But a true mechanism does not make every intervention appropriate for every person.

One system gave her reassurance without an explanation. The other gave her an explanation so large that managing it became a second occupation.

Neither system asked the same basic question.

What is this plan costing this particular person?

Evidence-based medicine is built from groups. That is its strength. A well-conducted trial can show whether an intervention helps more people than it harms, on average, under defined conditions.

The person across the desk is not an average.

She arrives with a particular childhood, family structure, metabolism, hormonal ground, financial reality, sleep history, caregiving load, and way of reading danger. She also arrives with a body that has adapted to those conditions for years.

Two patients can receive the same instruction and undergo different exposures.

“Exercise five days a week” may restore one person and deplete another. A detailed food plan may create useful structure for one patient and turn every meal into an examination for another. A wearable may reveal a pattern. It may also convert sleep into another performance she believes she can fail.

Same recommendation. Different body.

This is not an argument against guidelines. It is an argument for finishing the work guidelines begin.

The field of minimally disruptive medicine uses a useful distinction between workload and capacity. Workload includes everything illness and treatment ask a person to do. Capacity includes the physical, cognitive, social, financial, and environmental resources available to do it.

When workload repeatedly exceeds capacity, the patient does not simply become “noncompliant.” The plan becomes incompatible with the life in which it must operate.

My patient created a different problem. She increased her effort every time the plan exceeded her capacity.

She did not drop the task. She dropped herself.

That pattern looked admirable from the outside. It had probably been admired for most of her life.

She managed work, family, appointments, meals, refills, exercise, and everyone else’s emergencies. If a plan failed, she assumed she had not executed it correctly enough. She responded by becoming more precise.

The precision concealed the cost.

Her body had been adapting to sustained demand through the HPA axis, autonomic nervous system, immune signaling, and metabolism. These systems are designed to preserve function when circumstances require more from us. That adaptation is called allostasis.

Allostasis is not disease. It is protection.

The cost appears when the demand does not end. A response built for mobilization remains active, returns too often, shuts down too slowly, or becomes too depleted to respond normally. The accumulated biological price is called allostatic load.

That helps explain why the same life does not produce the same body in two people.

The event is not the whole exposure. The exposure also includes what the event meant, what came before it, what resources were available afterward, and what the person had learned they were permitted to need.

This patient had learned to answer strain with competence.

Her body followed.

It mobilized when she asked. It kept her functional. It carried one more responsibility, then another. It protected the life she had built until protection itself became expensive.

The body does not malfunction. It escalates.

The question that changed our visit was not which panel had been missed.

I asked what had quietly disappeared while she was becoming so good at taking care of herself.

She did not answer immediately.

Then she described several ordinary things she no longer did. Nothing dramatic. Time with her hands. Time without measurement. A part of the week that did not produce anything for anyone.

Her treatment plan had many instructions for the body. It contained almost no room for the person living in it.

That distinction matters clinically.

A plan can improve biomarkers while reducing function. It can lower weight while taking muscle. It can improve a sleep score while making the patient afraid of a bad night. It can produce flawless adherence while consuming the remaining capacity required for recovery.

None of those outcomes proves the intervention was wrong.

They prove that the subject must remain visible.

I began removing tasks.

Not because sleep, nutrition, movement, and medication had stopped mattering. Because the plan had to stop recreating the same condition we were trying to treat: a life in which she could never be finished.

We kept what had a clear purpose. We questioned what had been added by momentum. We watched function, sleep, recovery, and the return of ordinary desire, not only whether she completed the protocol.

The work became less impressive.

It also became more honest.

Months later, the detail she mentioned was not a laboratory value. She had begun making things with her hands again. It was something she had not done for years.

She did not describe it as recovery.

She said she recognized herself.

Evidence told us which interventions might help a patient like her. Only the subject could tell us whether those interventions still served the life she was trying to recover.

The folder remained organized.

It was no longer the most alive thing she carried into the room.

This essay uses a composite drawn from clinical encounters over many years. Names, ages, occupations, timelines, and identifying circumstances have been changed. No individual patient is depicted. The clinical pattern has been preserved.

Sources: May, Montori and Mair, “We need minimally disruptive medicine,” BMJ, 2009. Shippee and colleagues, “Cumulative complexity,” Journal of Clinical Epidemiology, 2012. McEwen, “Protective and damaging effects of stress mediators,” New England Journal of Medicine, 1998.

Every essay here starts in the exam room. Subscribing is free, and it's how the next one finds you.

If you know someone carrying a folder like hers, send this to them.

Share

What quietly disappeared from your week while you were busy taking care of your health? Tell me in the comments. I read them.

Leave a comment

Dr Shiv Kumar Goel is an internal medicine and functional medicine physician and founder of Prime Vitality Care in San Antonio. Across 25 years in hospitals, intensive care, and functional medicine, he has studied the gap between what medicine can measure and what patients actually live through. He writes Healing the Split and is the author of the forthcoming book The Unread Life.

Choose one behavior other people praise in you.

It may be answering every message. Training through exhaustion. Skipping lunch because the work matters. Saying yes before you have checked what the yes will cost.

Do not change it yet.

For seven days, write down four things when the behavior appears: what happened just before it, what you predicted would happen if you stopped, what your body was doing, and what the behavior cost you six hours later.

Keep the observation plain. Tight jaw. Missed meal. Faster pulse. Irritability at home. Waking at three. No interpretation is required.

At the end of the week, ask one question:

If the behavior involves prescribed treatment, nutrition for a medical condition, exercise restrictions, or medication, do not change it from a newsletter exercise. Bring the pattern to the clinician responsible for that care.

This practice goes with last week’s essay, The Day Discipline Became a Symptom.

Practices here are small, specific, and meant to be done, not admired. Subscribing is free, and it's how the next one finds you.

If someone you know is praised for the habit that is wearing them down, send this to them.

Share

Which behavior did you choose? Tell me in the comments. I read them.

Leave a comment

Dr Shiv Kumar Goel is an internal medicine and functional medicine physician and founder of Prime Vitality Care in San Antonio. Across 25 years in hospitals, intensive care, and functional medicine, he has studied the gap between what medicine can measure and what patients actually live through. He writes Healing the Split and is the author of the forthcoming book The Unread Life.

This case is a composite drawn from clinical encounters over many years. Names, timelines, occupations, and identifying circumstances have been changed. No individual patient is depicted. The clinical pattern has been preserved.

She said it once while describing the abdominal pain.

“I kept going.”

She said it again when I asked how long she had followed the diet.

Eight months.

No garlic. No onions. No wheat. No beans. No restaurant meals unless she had chosen the menu first.

She had started a low-FODMAP diet after years of bloating and unpredictable bowel symptoms. At first, it helped. Her abdomen felt quieter. The improvement was real.

Then the temporary restriction became the permanent plan.

She had never been taken through systematic reintroduction. Nobody had asked which foods actually caused symptoms. Nobody had helped her find the broadest diet her body could tolerate.

Instead, she became better at restriction.

She carried food to family gatherings. She declined dinner invitations. She read labels until eating required more vigilance than hunger.

“I kept going,” she said again.

I asked what happened when she tried a food outside the plan.

She did not describe the symptom first. She described the fear.

That changed the visit.

The diet was not wrong. The sequence had stopped halfway.

The American Gastroenterological Association describes the low-FODMAP approach in three phases: restriction for no more than four to six weeks, reintroduction, and personalization. The American College of Gastroenterology recommends only a limited trial, and grades the evidence as very low quality.

Restriction had given her useful information. It was never meant to become her identity.

We did not tell her to eat everything. We did not dismiss the symptoms as anxiety. We treated the fear and the bowel symptoms as different information.

She began with one food, one amount, on one ordinary day. Then she watched what happened.

Not what she feared would happen. What happened.

The goal was not perfect digestion. The goal was a life in which digestion did not make every decision.

At the next visit, she had added several foods back. Some still caused symptoms. Others did not. The list was smaller now.

So was the fear.

Near the end, she said it once more.

“I kept going.”

This time, she meant something different.

This case note is the companion to Tuesday’s essay, The Day Discipline Became a Symptom.

Case Notes are short stories from the exam room, the moments that change a visit. Subscribing is free, and it's how the next one finds you.

If someone you love has been on a “temporary” diet for months, send this to them.

Share

Have you ever kept going with a plan long after it stopped helping? Tell me in the comments. I read them.

Leave a comment

Dr Shiv Kumar Goel is an internal medicine and functional medicine physician, founder of Prime Vitality Care in San Antonio. Across 25 years in hospitals, intensive care, and functional medicine, he has studied the gap between what medicine can measure and what patients actually live through. He writes Healing the Split and is the author of the forthcoming book The Unread Life.

She handed me a list of forty-seven foods she no longer ate.

Not foods she disliked. Not foods she had casually decided to avoid. These were foods she had removed carefully, one after another, while trying to make her gut behave.

Her colonoscopy was normal. Her endoscopy was normal. The celiac panel, stool cultures, and basic inflammatory markers were unremarkable.

She had been told she had irritable bowel syndrome. She was advised to reduce stress, identify her triggers, and try a low-FODMAP diet.

None of that was unreasonable.

The low-FODMAP diet has evidence behind it. For some people with IBS, reducing fermentable carbohydrates can decrease bloating, pain, and unpredictable bowel movements. The American College of Gastroenterology recommends a limited trial.

Limited matters.

The diet was designed to move through stages. Restrict for a defined period. Reintroduce foods systematically. Then personalize the long-term diet around what the individual can actually tolerate.

She had completed the first stage with extraordinary discipline.

She had never reached the other two.

At first, removing food helped. A difficult evening followed a large meal, so she ate less. Wheat seemed connected to bloating, so wheat went. Then dairy. Then onions, garlic, apples, legumes, and most meals she had not prepared herself.

Each removal created a little less uncertainty.

It also created a smaller life.

She stopped going to restaurants unless she had studied the menu first. She carried her own food to family gatherings. She declined dinners because explaining the list felt harder than staying home.

Her gut was slightly quieter.

Everything around it had narrowed.

From the outside, this looked like discipline. She followed instructions. She tracked symptoms. She resisted temptation. She did not complain about the inconvenience.

Inside the body, something else was happening.

The plan had stopped being an experiment and become a system of vigilance. Every meal was screened for danger. Every sensation became evidence. Every flare justified another restriction.

The treatment was no longer only treating the symptom.

It had begun to resemble it.

This is where medicine often misreads the compliant patient. We are trained to worry about the person who does not follow the plan. We ask whether they understood it, could afford it, or were ready to change.

We are less suspicious of perfect adherence.

The chart says the patient is compliant. The clinician feels reassured. The patient receives praise for doing exactly what was asked.

But adherence is not proof that a treatment still fits.

Sometimes it is proof that the person has become very skilled at overriding themselves.

That distinction matters because two patients never receive the same intervention in the same body.

One brings a post-infectious gut. Another brings years of disrupted sleep. Another brings food insecurity from childhood, a caregiving load, a sensitized pain system, or a nervous system that learned early that control was safer than uncertainty.

The written recommendation may be identical.

The exposure is not.

Evidence tells us what tends to happen across groups of people. It helps us estimate benefit, risk, and probability. Without it, medicine becomes opinion dressed as confidence.

But evidence-based medicine was never meant to erase the subject.

In 1996, David Sackett and his colleagues defined it around decisions for individual patients. The model joined the best available research with clinical expertise. Later formulations made the patient’s values and circumstances explicit.

The evidence was one part of the encounter.

The person was always supposed to remain inside it.

That sounds obvious until the average and the individual separate.

The guideline can be right. The patient can follow it. The outcome can still be wrong for that person.

That is not evidence failing.

It is evidence being used without enough attention to the life receiving it.

In her case, the question was not whether food affected her gut. It did. Some sensitivities were real and worth respecting.

The better question was whether all forty-seven foods were still the problem.

So we stopped treating the list as settled fact.

We looked at sequence. What had happened before each restriction? How long had it been tested? Was the reaction reproducible? What else was happening that week? How had she slept? What conversation had occurred before the flare? What happened when the same food appeared on a quieter day?

The pattern was uncomfortable.

Food mattered. But the week often mattered more.

Her symptoms rose before difficult Mondays. They intensified during family illness. They softened on days when her body was not already carrying five other demands.

That did not make her symptoms psychological.

The HPA axis changes gut motility, secretion, blood flow, and pain signaling. The enteric nervous system and the brain communicate continuously. A colonoscopy can rule out visible structural disease. It cannot show what the gut does during traffic, grief, vigilance, or a conversation the body has learned to anticipate.

Her normal scope was important.

It was not the whole story.

We did not replace one rigid protocol with another. We did not order ninety tests. We did not give her a larger supplement stack.

We widened the experiment.

She began reintroducing one food at a time. Slowly. She tracked symptoms beside sleep and stress, not food alone. She walked after dinner because movement helped without turning recovery into another performance.

Six weeks later, she had not reclaimed forty-seven foods.

She had reclaimed four.

Lentils on a Tuesday. Oats on a Saturday morning. A small apple, twice. Then dinner at her sister’s house, with nothing packed separately in a bag.

Four foods do not look dramatic in a medical record.

A life becoming wider does.

I asked what had helped most. She did not name the reintroduction schedule. She did not name the walk or the food log.

She said someone had finally explained what her gut was doing.

Her gut had not been lying to her. It had been reporting from the place where food, immunity, memory, and stress meet.

She had been disciplined because she wanted her life back.

The work began when discipline stopped being the only thing we measured.

Case disclosure: This essay is drawn from an approved composite in the manuscript. Names, timelines, clinical details, and identifying circumstances have been changed. No individual patient is depicted. The clinical pattern is preserved.

I write Healing the Split for people whose tests came back normal and who still don't feel normal. Subscribing is free, and it's how the next essay finds you.

If someone you love is living off a list like hers, send this to them.

Share

Have you ever followed a plan perfectly and watched your life get smaller? Tell me in the comments. I read them.

Leave a comment

Dr. Shiv Kumar Goel is an internal medicine and functional medicine physician based in San Antonio, where he founded Prime Vitality Care. With over 25 years of experience spanning hospital critical care and functional medicine, he specializes in the gap between what medicine can measure and what patients truly live through. He is the author of the forthcoming book The Unread Life and writes the Healing the Split newsletter.

Five minutes, a piece of paper, and three lines you write for nobody but yourself

I don’t open the chart first anymore. I ask two questions, and most of what I need is usually sitting inside the answers. Here’s how to ask them at your own kitchen table.

Five minutes. Something to write with. Do it alone.

Write one line naming the thing that’s been bothering your body lately. Not the diagnosis, if you have one.

The sensation itself, in whatever words you’d use if nobody medical were listening.

Where it sits. What it feels like when it’s worst.

Write a second line answering this. What was happening in your life in the months before it started.

Don’t reach for the dramatic answer if the true one is quieter.

A promotion counts, and so does a move, and so does the year where nothing happened on paper while everything was happening underneath.

Most people start by saying nothing, and then keep talking for a while. Let yourself keep talking.

Write a third line answering this one. Where have you felt this exact bracing before.

Whose reaction does yours remind you of.

Let whatever name or face shows up, show up. You don’t have to do anything with it.

Then read the three lines once, out loud if you’re alone, and put the paper down.

That’s the whole practice.

It should feel unfinished. The patient I wrote about last week answered the third question with one sentence about her mother and the phone ringing at dinner, and that sentence turned out to be the eight months.

Two things before you try it.

This doesn’t replace a workup, and it isn’t meant to.

A symptom that’s new or changing or getting worse belongs in front of a doctor first.

And if what surfaces on that third line is bigger than five minutes, that isn’t the exercise failing. That’s real, and it belongs with someone trained to sit with it.

Keep the paper. Bring it to your next appointment and put it in your pocket.

Hand it over or don’t. Most patients already know. Almost nobody gets asked.

Subscribe below if you want the next one, and write back if you actually try this, because I read those.

Subscribe now

Dr. Shiv Kumar Goel, MD, is an internal and functional medicine physician in San Antonio. Founder of Prime Vitality Care and author of the forthcoming book The Unread Life.

She kept a legal pad next to her in every meeting. Not for notes. For her stomach. Writing gave her hands something to do besides press against her side under the table.

She isn’t a patient. She’s a composite. I’ll call her Nora. If you’re one of mine and something here lands close, it isn’t about you. It means I’ve seen it too many times to count.

Thirty-two. Litigation associate. The kind of patient who apologizes for taking up your time while describing eight months of intermittent gut pain and hair coming out in the shower drain in strands she’d started counting.

She had already been through gastroenterology, twice. Celiac panel clean. Colonoscopy clean. Dermatology called the hair loss telogen effluvium, likely stress related, come back in six months if it doesn’t slow down. Endocrinology checked her thyroid. Normal. Everyone told her, kindly, that she seemed stressed.

She didn’t disagree. But stressed about what, she kept asking. Nothing had happened. She’d actually just made partner track.

I asked her the same two questions I ask almost everyone before I look at a single lab value. What was happening in your life in the months before this started. She said nothing, truly, that was the confusing part. Then I asked the second question differently than I usually do. Not how are you sleeping. What did fear sound like in your house growing up.

Nora went quiet longer than the question should have taken.

Her father lost his job when she was nine. It took him almost two years to find steady work again. She remembered the house getting quiet in a specific way. Mail left unopened on the counter for a day before anyone could face it. The phone ringing at dinner and her mother’s face going still before anyone answered it. Nobody explained any of it to her. She just absorbed the bracing.

She never lived that job loss. She lived the flinch that came after it, passed to her whole and intact, like a piece of furniture nobody remembers buying. Now an email from a senior partner sitting unread in her inbox produced the exact same physical seizing her nine-year-old body learned in that kitchen.

Her gut had been living in that kitchen for eight months. Her hair follicles had been keeping the same schedule.

Last week I wrote about a patient whose anxiety had been calibrated by a mother who was always at the edge. This one belonged to a father’s silence instead of a mother’s fear. The mechanics were identical.

Her ferritin had been checked. Somebody had run it early on and it came back inside the reference range, so it got a line through it and nobody looked again. That is the part I want other doctors to sit with. Normal is a very wide word. A ferritin in the low thirties clears the lab’s threshold and still leaves a woman shedding hair, and the reference range was never built to answer the question she was actually asking. I don’t think it explained everything. I think it was doing quiet work in the background while everyone looked elsewhere.

Her cortisol curve was the other thing. Blunted at 8 a.m., still elevated at 10 p.m., running backward from the shape it should have. I’ll be honest about what that is and isn’t. Most endocrinologists don’t use four point salivary cortisol and don’t consider it validated for this, and they have reasons. I use it the way I’d use a photograph. It isn’t proof of anything. It’s a picture that either matches the story the patient is telling or doesn’t, and hers matched.

So we treated the ferritin. And we spent more time than most visits allow on her mornings and her nights, because that curve doesn’t move without them. Light in her eyes within an hour of waking. Protein at breakfast instead of coffee on an empty stomach. A real stop to the screen at night, which for a litigation associate is closer to a negotiation than a prescription.

Then one small thing that I think mattered more than either. She stopped opening concerning emails the moment they arrived. Subject line only, then the laptop closed for ten minutes before she let herself read the body of it. Long enough for her nervous system to notice that nothing had actually happened yet.

Three months later her hair loss had stopped. The gut pain came only rarely, and briefly.

Here is what I can’t tell you. Telogen effluvium usually resolves on its own in three to six months. Her hair probably would have stopped falling out on schedule whether I’d been in the room or not, and any dermatologist reading this is already thinking it. I can’t separate what we did from the clock, and I’m not going to pretend otherwise.

What I can vouch for is the other thing.

She stopped bracing.

That was the part nobody had treated, because nobody had named it, and it wasn’t going to resolve on its own in three to six months.

Bodies don’t outgrow a flinch. They just get better at hiding it inside a symptom that looks like something else.

Nora told me, almost laughing, that she’d started leaving her mail on the counter overnight sometimes. On purpose. Just to see what it felt like to not need to know right away.

Subscribe now

Dr. Shiv Kumar Goel, MD, is an internal and functional medicine physician in San Antonio. Founder of Prime Vitality Care and author of the forthcoming book The Unread Life.

Five specialists in two and a half years. None of them asked the right question. The answer was in a sentence she said almost smiling.

Maya’s husband called ahead of the appointment.

He was a chiropractor, methodical and devoted. For two and a half years, he did what people do when they love someone and can’t fix them. Reading everything ever written about every diagnosis she had been given, in case understanding it would somehow stop it.

By the time they sat in front of me, he had become, out of sheer desperation and love, a walking encyclopedia of her chart.

He brought the binders. The MRI discs. The lab printouts organized by date. The skin biopsy reports. The neurology notes. The rheumatology workup. The ophthalmology exam. Dermatology. GI. All of it.

I told him I would look at everything he had brought. But first I wanted to just talk with her.

Forty minutes. No chart open. No binder. Nothing between us but a question and whatever she was willing to say.

What five specialists had not asked

Two and a half years earlier, her father had died. Then, just days later, her brother. Two losses arriving almost simultaneously, before she had finished absorbing the first one. Grief stacked on grief, with no pause between them, and no room in her life for either.

A few weeks later, she developed severe pain in a tooth. The kind of acute physical emergency the body produces when emotional pain has nowhere else to go. She ended up in a dental chair.

After the procedure, an infection. Her dentist prescribed clindamycin. Days later, a rash appeared across her body. Then headaches. Then shooting pain down one side of her face. Then severe problems with the eye on the same side. Pain, blurred vision, light sensitivity that would not resolve.

Neurology got her first. CT and MRI were negative. EEG was negative. The episodes came in clusters that didn’t fit a clean seizure pattern, didn’t fit a clean migraine pattern, didn’t fit anything with a tidy billing code. She was given pain medication and gabapentin and sent forward.

Dermatology performed a skin biopsy. Inflammatory dermatitis. A real finding, a real name. But a description of what the skin was doing, not an answer to why. Steroids helped temporarily. The rash kept returning.

Ophthalmology found nothing structural. Prescribed new glasses.

By the time rheumatology saw her, her ANA was elevated. But none of the other markers were consistent with any recognizable autoimmune pattern. Lupus lacked this. Sjögren’s lacked that. Vasculitis didn’t quite fit.

The rheumatologist documented what was honest: autoimmune disease of uncertain etiology, pending further workup.

A name that meant: something is happening, and we cannot find the box it belongs in.

The sentence that completed the map

Before I opened a single file in Maya’s chart, I asked two questions that none of the prior notes contained the answer to.

What was happening in your life in the months before the dental procedure?

She told me about her father. Then her brother. Then the tooth pain that arrived in the middle of all that grief.

How have you been sleeping?

She had not slept well since her father died. Her husband confirmed: she barely ate, could not keep much down. He had stopped pushing food because watching her try to eat and then vomit was harder than accepting the liquid calories she would tolerate.

And then, almost as an aside, almost smiling when she said it:

I’ve always had anxiety. I got that from my mother. She was always at the edge. I grew up watching her, and I suppose I caught the habit.

The map was complete.

What I was looking at was not five separate conditions affecting five separate organ systems. It was one person whose losses had never been processed. Whose nervous system had been running in threat-response since childhood. Inherited, trained, passed forward from a mother who was always at the edge.

Her immune system, already depleted by grief and sleeplessness and barely adequate nutrition, had been pushed past its threshold by an antibiotic that disrupted her already-fragile gut microbiome.

The rash. The facial pain. The eye involvement. The elevated ANA without a clean pattern.

This was not a disease without a name. It was a body without a witness.

A body without a witness will eventually find a way to testify.

What gets passed down without being said

Maya had mentioned her mother almost in passing.

I caught the habit. The way people mention things they have carried so long they no longer feel their weight.

But she was describing something researchers have spent two decades documenting with increasing precision.

Rachel Yehuda’s group at Mount Sinai studies Holocaust survivors and their children. They’ve found measurable epigenetic marks on the glucocorticoid-receptor gene passed down to offspring. Those children never experienced the original trauma. They inherited the calibration anyway.

Brian Dias and Kerry Ressler at Emory conditioned male mice to fear a specific odor, then found that their offspring, who had never been exposed to that conditioning, showed heightened sensitivity to that exact smell. The transmission was mediated by methylation changes in sperm DNA.

A 2025 study on Syrian refugee families found specific DNA methylation changes associated with war-related violence in people whose only exposure to that violence had been through their parents and grandparents.

The experience of the previous generation had been encoded in the next generation’s nervous system before that generation was born.

Maya did not catch anxiety the way you catch a cold. She inherited a calibration. A nervous system doesn’t ask where the fear came from. It just runs the program it was handed. A stress-response threshold set by her mother’s unresolved load, passed forward in the most intimate way possible. Written into her biology before she had language for any of it.

What looked like a body breaking down was actually a body running a program older than she was.

What the labs finally said

I ordered what I needed to confirm what I already understood.

Severely dehydrated. Profoundly anemic. Iron, B12, folate, and vitamin D critically depleted. Her four-point salivary cortisol curve was almost completely flat. An adrenal system that had been running at emergency capacity for so long it had lost the ability to cycle. Testosterone negligible. Estrogen low. Progesterone barely detectable. Her secretory IgA, the immune system’s first line of defense in the gut and mucosal tissues, suppressed in exactly the pattern you see when the stress response has been running without interruption for a prolonged period.

Her basic labs had been fine. Her biology was not.

We started IV hydration immediately. Parenteral replacement of every depleted nutrient. A short course of low-dose hydrocortisone with DHEA. Box breathing twice a day. Not as a wellness gesture. As a direct physiological intervention to activate the vagal brake and signal to the nervous system that the emergency level could come down.

A few days later she called. She could feel the beginning of facial pain and shooting sensations returning.

I knew immediately what it was. Herpes zoster. Shingles. The varicella virus that had been dormant in her nervous system since childhood, held quiet by a functioning immune system. But her immune system had not been functioning. It had been depleted for months. The virus had been waiting for exactly this opening.

The label had been wrong from the start. What she had was zoster, progressing along a nerve pathway, in a woman whose immune system had been too suppressed by grief, malnutrition, and adrenal exhaustion to mount a response.

Valacyclovir. Nutritional rebuilding. Bi-est, progesterone, testosterone. The body finally getting back what the years of running on empty had quietly taken from it.

Two months later, she called me from Peru. She had gone to visit her surviving brother. She was eating. She was sleeping. The pain was gone. The rash was gone. The fog had lifted.

I feel like I got a new life, she said.

Call it what you want. What she got was the life her body had been trying to return to since the day her father died, since the grief had nowhere left to land.

What I want you to know

If you have been told repeatedly that your labs are fine, and your body is clearly telling you otherwise, your body is not lying. The instrument is incomplete.

And if you grew up inside a nervous system that was always at the edge, that calibration is not a personality. It is a physiology. It is also reversible, in the sense that the body never stops trying to return to the life it was built for.

The five specialists who saw Maya were not wrong. They were positioned, each of them, in their particular window. None of those windows opened onto her father. Or her mother’s nervous system. Or the dental chair, the place where the grief had finally found a doorway out.

The body keeps its own record. Sometimes the work of getting well is finding the physician who knows how to read it. And learning, slowly, how to read it yourself.

References

Yehuda R, Daskalakis NP, Bierer LM, et al. Holocaust exposure induced intergenerational effects on FKBP5 methylation. Biol Psychiatry. 2016;80(5):372-380.

Dias BG, Ressler KJ. Parental olfactory experience influences behavior and neural structure in subsequent generations. Nat Neurosci. 2014;17(1):89-96.

Mulligan CJ, Quinn EB, Hamadmad D, et al. Epigenetic signatures of intergenerational exposure to violence in three generations of Syrian refugees. Sci Rep. 2025;15(1):5945. doi:10.1038/s41598-025-89818-z.

Shiv Kumar Goel, MD, is an internal medicine and functional medicine physician in San Antonio, with over two decades in hospital and critical care medicine. He is the founder of Prime Vitality Care and TimeVitality, and the author of the forthcoming book The Unread Life. He writes the Substack of the same name at healingthesplit.com. All patient details have been altered; cases are composites drawn from twenty years of clinical practice.

William did not come in to talk about his heart.

He came for a men’s-health visit — erectile dysfunction, some fatigue, nothing dramatic. He was 55, stressed, tired, and quietly worried that he no longer felt like himself.

His primary care doctor had recently told him his cholesterol looked normal and his risk was low. He believed it. His numbers looked fine: LDL-C 108 mg/dL, HDL-C 52 mg/dL, triglycerides 118 mg/dL, total cholesterol 182 mg/dL.

But in midlife men, erectile dysfunction is often an early vascular clue. Men with ED carry higher future rates of cardiovascular disease, stroke, and death than men without it (2019 meta-analysis; Circulation: Outcomes analysis). None of that made him a cardiac patient. It did mean the routine panel had left the real question open.

So we looked further, at two markers that refine risk when a standard panel comes up short (2026 ACC/AHA dyslipidemia guideline).

Erectile Dysfunction Is Often Vascular Data, Not Just “Performance”

When a midlife man arrives with erectile dysfunction, the system tends to file it as a local problem — performance, mood, testosterone. The cohort data argue otherwise. Across prospective studies, men with ED run a higher future risk of cardiovascular events, coronary heart disease, stroke, and death, even after adjusting for the usual risk factors, with relative risks commonly between 1.3 and 1.6 for major outcomes (prospective cohort analyses; umbrella reviews). ED tends to arrive early, ahead of an event, not after it (narrative reviews).

The signal is strongest in William’s group. Risk runs higher in intermediate-risk men and in younger men in their 40s and 50s — the very men most likely to be reassured by a normal cholesterol and a quick calculator (mortality-focused meta-analysis). For them, ED is often the first sign the endothelium is falling behind, years before a conventional event.

That reshapes what an ED visit is for. A man in his 50s with new erectile dysfunction, central weight gain, and a family history of early heart disease deserves more than a phosphodiesterase inhibitor and a testosterone level. He deserves an honest cardiovascular look: blood pressure, fasting glucose and insulin, ApoB and Lp(a), and, in the right case, a coronary calcium score (advanced lipoprotein markers).

Not every case of ED needs a cardiac workup. But in a midlife man, it should stop being filed as a purely local complaint when his vascular system may be telling the truth first.

Why “Normal Cholesterol” Can Mislead

Cholesterol does not move through the blood on its own. It rides inside lipoprotein particles — and in many people, the number of atherogenic particles predicts arterial risk better than the cholesterol concentration does. A 2025 systematic review of discordance studies put ApoB ahead of both LDL-C and non-HDL-C as a risk marker (2025 systematic review).

LDL-C tells you how much cholesterol sits inside LDL particles. ApoB estimates how many atherogenic particles are carrying it. When the two agree, the standard panel works. When they diverge, the panel can read reassuring while particle burden runs high (recent discordance analyses).

Two men can share an LDL-C. One carries it in relatively few particles; the other spreads it across many more, often alongside insulin resistance or higher triglycerides. The cholesterol number matches. The arterial exposure does not.

So the sharper question is not whether your cholesterol is normal. It is how many atherogenic particles you carry, and what you inherited.

What ApoB and Lp(a) Add

Cholesterol is not the villain. It builds cell membranes, steroid hormones, bile acids, vitamin D, and the structure of nerves. Lipid therapy is not trying to erase it. It is trying to lower the number of ApoB-containing particles that can lodge in the artery wall (current dyslipidemia guidance).

Every atherogenic particle — LDL and VLDL remnants alike — carries a single apolipoprotein B. So ApoB counts the particles most able to do damage. LDL-C is the cholesterol in circulation; ApoB is how many potentially atherogenic vehicles are on the road.

William’s ApoB came back at 102 mg/dL — more particle burden than his routine panel implied, and above the roughly 80 mg/dL considered optimal for a man carrying added cardiovascular risk. His LDL-C looked acceptable. His particle count was not.

Then there was Lp(a), or lipoprotein(a). It is largely inherited, stays stable across life, and never appears on a standard panel unless someone asks for it. William’s measured 68 mg/dL, above the 50 mg/dL mark used to flag elevated risk. Guidelines now support measuring it once in adulthood, because it sharpens risk in ways nothing else on the panel can (ACC; AHA Lp(a) initiative).

His cholesterol panel read reassuring. His risk picture did not.

How to Actually Use ApoB and Lp(a)

Advanced lipids earn their place only when they change the decision in the room.

ApoB matters most when the story hints at discordance — a borderline LDL-C paired with higher triglycerides, central weight, prediabetes, or a strong family history of premature heart disease. In those patients, particle number and cholesterol concentration have often parted ways, and an ApoB moves the risk from uncertain to actionable (ApoB discordance literature).

What you do with it depends on context. For primary prevention without known disease, current guidelines set LDL-C goals under 100 mg/dL across low-to-intermediate PREVENT risk, and under 70 mg/dL at high risk. ApoB refines those calls, flagging people whose particle burden outruns their LDL-C, especially at an ApoB of 120 mg/dL or higher, or when several risk enhancers cluster (2026 multisociety guideline summary).

Lp(a) works differently. You measure it once, not repeatedly (National Lipid Association summary). An elevated level raises baseline risk for atherosclerotic events and aortic valve disease, argues for tighter LDL-C and ApoB targets, and justifies screening across the family, since the trait is inherited.

A borderline-risk man with a strong family history of early heart attack and a high Lp(a) is not the same patient as one with identical calculated risk and a normal Lp(a). In the first, the threshold to start a moderate-intensity statin, tighten blood pressure, and push harder on lifestyle is easier to cross.

For patients, the move is simple: if the numbers and the family story do not match, ask whether ApoB and Lp(a) have ever been checked. Your biology may be carrying information the basic panel never recorded.

What the Evidence Shows

Three points hold up.

ApoB catches risk that LDL-C misses when the two diverge, and in that situation it is the more accurate marker. Elevated Lp(a) is not a lab curiosity — it is an independent, causal driver of atherosclerotic disease and aortic valve disease, which is why guidelines now call for measuring it once in every adult. And lowering ApoB-containing lipoproteins reduces events in the right patients, particularly higher-risk people already on standard therapy (current guideline summaries).

None of that means every person with a normal LDL-C and a high ApoB needs aggressive treatment tomorrow. In primary prevention, baseline risk still governs. The USPSTF recommends a statin for adults 40 to 75 with at least one risk factor and a 10-year risk of 10% or more, and a more selective approach between 7.5% and 10% (USPSTF recommendation).

A normal panel can hide real risk, and treatment intensity still has to fit the whole patient. Both are true.

How the Guidelines Think About “Borderline” Risk

For people without known heart disease, the hard calls sit in the middle — not the low-risk 25-year-old or the high-risk 68-year-old, but the 45-year-old whose cholesterol looks fine on paper and whose calculator says “borderline.”

The USPSTF keeps it simple: for adults 40 to 75 without cardiovascular disease, a statin when there is at least one risk factor and a 10-year risk of 10% or more, and a more selective approach from 7.5% to 10%. Past 76, the evidence runs out (USPSTF recommendation).

The 2026 ACC/AHA multisociety guideline uses the newer PREVENT equations instead of the older pooled cohort equations, and layers risk enhancers on top (2026 guideline press release). PREVENT gives 10-year and 30-year estimates for adults 30 to 79 and sorts risk into low, borderline, intermediate, or high.

The enhancers tilt the call: family history of premature disease, chronic inflammation, high triglycerides, metabolic dysfunction, kidney disease, high ApoB, and elevated Lp(a).

Take a man at borderline or intermediate PREVENT risk who also carries a high Lp(a), a higher ApoB, central weight, and a sibling who had a heart attack at 52. The guideline frame supports treating him earlier and more assertively — a statin, tighter lipid targets, and often a coronary calcium score to see whether atherosclerosis is already underway (JAMA Cardiology editorial).

The rule is not that everyone at 7.5% gets a statin. It is that baseline risk, risk enhancers, family story, and advanced lipids belong in one conversation. When they line up toward higher risk, waiting for the first event stops being a neutral choice.

Why the Same “Normal” Doesn’t Mean the Same Thing

If two people can share an LDL-C and not a risk, the reasons are worth naming.

Insulin resistance, visceral fat, and higher triglycerides push the body toward more atherogenic particles without moving LDL-C much. Genetics shape both Lp(a) and the tendency toward discordance. Even the measurement matters — LDL-C is usually calculated, not measured directly, and the estimate drifts when triglycerides run high (ApoB review literature).

Your neighbor’s normal panel is not a verdict on your arteries.

It is also why both halves of modern medicine miss this. Routine care underuses ApoB, so hidden risk goes unmeasured. Aggressive longevity and functional practices overcorrect, treating every off-range biomarker as a disease. Neither reflex helps. Better measurement, then better interpretation, does.

HDL shows the trap. A low HDL is a useful marker, but raising it with drugs has not reliably reduced cardiovascular events in trials (systematic review and meta-regression). Low HDL is a reason to look upstream, not a target to chase.

Advanced Lipids Are Tools, Not Identity Labels

Advanced lipids can clarify risk. They can also be abused.

Conventional care errs by omission — never ordering ApoB or Lp(a) in the very patients whose stories point straight at discordance or inherited risk. The wellness and longevity world errs the other way, ordering enormous panels and treating every flagged line as its own disease.

The pattern is familiar. A patient arrives having had LDL particle number, oxidized LDL, Lp-PLA2, small dense LDL, and a fistful of proprietary scores measured. He has been told everything is wrong and put on a stack of supplements, a restrictive diet, and a schedule of expensive repeat testing. Strip it back, and the two signals that mattered were a high ApoB and a high Lp(a) — reachable with far fewer tests, and enough to guide real decisions about statins, lifestyle, and family screening (ApoB; Lp(a) consensus guidance).

The cost of over-testing is not only money. It turns biology into identity. Patients start describing themselves as oxidized-LDL types or particle-number types, even where those markers were never tied to outcomes the way ApoB and Lp(a) are. Risk becomes a brand. The nervous system burns its energy tracking panel changes instead of tracking whether the person is actually moving toward safer ground.

The honest use of advanced lipids is narrower. Order ApoB and Lp(a) when they will change a decision. Read them against guideline thresholds, family history, and the body in front of you. Then fold them back into the question that governs the rest of care: what, in this particular person, is happening that the standard instruments have only half seen?

What I Tell Patients in Clinic

When the routine panel looks acceptable but the picture does not, two measurements help: ApoB and Lp(a). ApoB estimates current particle burden. Lp(a) reveals inherited risk the standard panel will never show, and once in adulthood is enough (current guidance).

It earns its place when the numbers do not fit the person — a family history of early heart disease, central weight gain, prediabetes, higher triglycerides, or a vascular clue like midlife ED. There, a normal LDL-C is not the end of the conversation. It is where the better question starts.

When treatment is warranted, the answer is not always the most aggressive drug on the shelf. In primary prevention, baseline risk, tolerance, and preference still count, and shared decision-making belongs there.

William understood the science. He understood that his routine panel had not told the whole story. He still chose to wait, and I did not push him.

A more accurate risk picture does not force every patient to the same decision. It does force us to stop mistaking normal cholesterol for a finished cardiovascular assessment.

Questions to Bring Into the Visit

If your cholesterol looks fine but something still nags at you, these are quetions worth bringing to your next visit — 

1. “My cholesterol came back normal, so how do you actually know how likely I am to have a heart problem someday?” This nudges your doctor toward a real risk estimate with tools like PREVENT instead of a rough guess.

2. “Should we check my ApoB? With my triglycerides, my weight, and heart disease in my family, I’m not sure the regular cholesterol test tells the whole story.” ApoB can show particle risk a standard panel misses.

3. “Has anyone ever checked my Lp(a)? Heart trouble runs in my family, and I heard it’s a one-time test.” Current guidance supports checking it once in adulthood.

4. “If I’m kind of on the fence, what would make you lean toward starting a statin — and what would make you say let’s wait?” The USPSTF thresholds are a good anchor for that talk.

5. “Would one of those heart calcium scans actually tell us whether I need medication right now?” In in-between cases, the score often moves the decision one way or the other.

6. “Besides pills, what could I actually do that would move my numbers — my ApoB, my blood pressure, my weight?”

7. “If my ED might be an early warning for my heart, how do we take it seriously without going overboard on tests?”

That last one holds the ground the evidence supports: neither brushing the symptom off nor turning it into a sales pitch, but reading it as data.

If the panel looks fine but the picture does not, the goal is not more tests. It is the right two — and a more honest conversation about what they mean.

Enjoyed this breakdown?

The Life Beyond Labs series examines one health question at a time — without the hype in either direction.

For deeper clinical essays on what medicine often misses and what patients actually feel, subscribe to my Substack: Healing the Split

I publish there first, for readers who want more than a test result.

About the Author

Dr. Shiv Kumar Goel, MD, is an internal medicine physician in San Antonio, Texas, trained at Mount Sinai, and the founder of Prime Vitality Care. He is the author of the forthcoming book The Unread Life.

He is the author of What Medicine Misses and Patients Feel (forthcoming) — a clinically grounded, human account of the gap between what standard medicine can see and what patients actually experience.

To follow his work: drshivgoel.com To reach him directly: contact@drshivgoel.com

Patient details including name, age, timeline, and identifying circumstances have been changed. William is a composite drawn from clinical encounters over many years of practice. No individual patient is depicted or identifiable.

One day you wake up. Same walls. Same ceiling. Same people.

But something has shifted.

The place you have been calling home — you see it now as a cage.

Not because it changed. Because you did.

This is the moment no one warns you about. They talk about the breakthrough. The awakening. The turning point. They make it sound like freedom arrives with applause.

It doesn’t.

It arrives as a quiet, disorienting terror. The walls look the same. Your name is still on the door. The people inside still love you in the only way they know. But you can see the bars now. And once you see them, you cannot unsee them.

I have sat with this in my own life. I have watched it in patients.

The physician who has been practicing for twenty years and realizes she has been practicing someone else’s medicine. The son who has run the family business for a decade and wakes one morning knowing he was never meant to be there. The woman who has kept everything together and suddenly cannot explain why the keeping together feels like it is slowly killing her.

Good labs. Bad life. There’s a reason.

The reason is not weakness. It is not ingratitude. It is not crisis.

It is biology finally saying what biography never let you say.

The ones who feel caged do not become more caged when they start to see clearly. They were always caged. The clarity is not the problem. The clarity is the beginning.

The guards at the door — the ones who tighten their grip the moment you start asking questions — they are not your enemies. They are loyal to the only architecture they have ever known. Your seeing threatens their certainty. That is not malice. That is fear wearing the mask of care.

The reformers — the ones who arrive with the language of liberation and offer you a newer, cleaner cell — they are the most dangerous. Learn to feel the difference between the one who opens the door and the one who just moves it.

Here is the harder truth.

The prison was not built by your enemies. It was built by people who lived inside one too. They handed it to you as shelter. They called it home because it was the only home they had.

They created the split. You carried it without knowing.

This is what breaks open when I sit with a patient who is doing everything right and still feels like a stranger in their own life. It is not their failure. It is an inherited structure. The body is doing what biography asked of it — loyally, faithfully, until it cannot anymore.

The body does not malfunction. It escalates.

Not everyone who sees the prison wants to leave.

I want to be honest about that.

[Patient composite — all identifying details modified]

A man I’ll call Dev is in his late fifties. Spent his career in a demanding field that ran on hierarchy and protocol — you followed the chain, you did not question it. He came in a few months ago for insomnia. His wife had just passed. Over two decades together. No children.

I have known him for a while.

He is not a man who questions the architecture around him. He followed the rules. He built the life he was told to build. His wife, in her own quiet way, agreed with everything — which did not give him a mirror. It gave him an echo.

Now she is gone. And for the first time in his life, no one is telling him what to do next.

He told me his life is over.

He is on antidepressants. He is seeing a therapist. We are doing what the situation calls for.

But sitting with him, I heard something underneath the insomnia, underneath the grief. He is not lost because she died. He is lost because the warden just left.

The prison is all he has ever known. The walls are the only grammar he has for the word home.

I did not try to show him the door.

Some people are not ready for it. Some people, at this point in a life, need the walls to still be there. To take that from him — in the name of liberation — would be its own kind of violence.

I listened. I renewed his prescription. I told him to come back.

That is also medicine.

Out beyond ideas of wrongdoing and right doing,

there is a field.

I’ll meet you there.

— Rumi

So how do you leave, when you are the one who is ready?

Not by breaking harder. The more force you bring to the bars, the more the structure tightens around the force. That is not a metaphor. The HPA axis reads threat. The nervous system braces. The biology follows. You cannot heal in a body that is still bracing for impact.

You leave the way water leaves — through the crack that was always there.

The way of the whisper, not the shout. The inner knowing that was never lost. Only silenced. Only buried under the noise of the biography you were handed.

You never needed the map. You have the GPS built inside each fabric of yours.

The world outside does not reward you for leaving. No parade. No applause. For a while, the ones you love most will not understand. They may resist. They may grieve the version of you that stayed.

That is not your failure.

It is the natural consequence of becoming more clearly yourself in a space that was built around a smaller version of you.

I don’t know where you are reading this. Maybe at midnight. Maybe in the car after a long day when the house felt too quiet and too full at the same time. Maybe on a Sunday night when the weight of the week ahead feels like it belongs to someone else’s life.

But I know this.

The fact that you can see it — really see it — is not the problem.

It is the way.

The body has been waiting a long time. This is the first time you agreed to look.

Dr. Shiv Kumar Goel, MD, is an internal medicine physician in San Antonio, Texas, trained at Mount Sinai, and the founder of Prime Vitality Care. He is the author of the forthcoming book The Unread Life.

Move more. Eat real food. Sleep. Don’t smoke. All true. All necessary. And it’s also where most people stop.

The patients who age slowly — the ones whose bodies look a decade younger than their charts — almost always do a few quieter things the headlines skip. None of these replace strength training or a decent diet. They sit on top of the basics, cost almost nothing, and target the parts of aging we usually ignore until they’re already gone: balance, metabolic flexibility, and the biological signal you can actually track.

These are the three I do myself, every morning, and prescribe to patients every week.

1. I Stand on One Leg While I Brush My Teeth

Why this matters

We spend enormous energy worrying about heart disease and almost none worrying about balance — until a fall happens. That is backwards.

Falls are among the most life-altering events in later life. They are a leading cause of injury-related death in older adults, and more than that, they are often the starting point for a cascade: a fracture, then immobility, then muscle loss, then the loss of independence that was never supposed to come this soon. What makes this particularly frustrating is that balance is not a fixed trait. It is a trainable skill, at any age. The nervous system and the muscles that hold us upright respond to practice the same way any other physical capacity does — if you ask them to work, they maintain. If you never ask, they quietly decline.

What the research actually shows

The one-leg balance test looks simple. It is not.

A 2022 study in the British Journal of Sports Medicine followed 1,702 middle-aged adults and found that those who could not hold a 10-second one-leg balance had an 84% higher risk of all-cause mortality over the following decade, even after controlling for age, sex, BMI, and underlying health conditions. That is not a minor signal. An 84% higher risk of death from failing a test that takes ten seconds to administer — a test that costs nothing, requires no lab, and can be done in a clinic hallway.

A separate longitudinal cohort study from the UK’s MRC National Survey of Health and Development followed over 2,000 adults from age 53 to 68. It found that those with consistently low balance scores at age 53 — before most chronic disease had declared itself — had more than three times the risk of recurrent falls by age 68 compared to those who could sustain balance for 30 seconds. That is a 15-year window between the signal and the consequence.

Balance is also one of the few measures that captures neuromuscular aging — the slow loss of coordination between the brain’s motor signals and the muscle’s capacity to respond — before it becomes visible. By the time a patient tells me they feel unsteady, the decline has already been building for years. The balance test catches it earlier, and earlier is when it’s still reversible.

What I do

Two minutes per leg, every morning, while I brush my teeth. I stand near the counter at first. Eyes fixed on one point. Breathing normal. I don’t rush it. Once 30 seconds feels easy, I increase difficulty: close the eyes for a few seconds to remove visual stabilization, or count backwards from a hundred to add cognitive load. That dual-task balance challenge mimics the real-world scenario — navigating a parking lot while thinking about something else — which is exactly when most falls happen.

If you haven’t done this in a while, start with eyes open and a hand available. The goal in week one is just to notice how it feels. Most people are surprised by how much harder it is than they expected.

2. I Take a 10-Minute Walk Right After I Eat

Why this matters

A great deal of what we call “aging” is accumulated metabolic wear — the slow damage that compounds from years of repeated blood sugar excursions after meals. Every time blood glucose spikes steeply and stays elevated, it drives a wave of low-grade inflammation, accelerates glycation of proteins and tissues, and adds to the biological debt the body has to service.

The most effective intervention I know for blunting those spikes is not a supplement. It costs nothing. It does not require a prescription. It is gentle movement in the thirty minutes after eating.

What the research shows

The data here is consistent across multiple populations and study designs.

A 2025 randomized crossover trial published in Scientific Reports found that a 10-minute walk taken immediately after a glucose load significantly reduced peak postprandial glucose and total glucose area under the curve, compared to both sitting and to a 30-minute walk taken 30 minutes after eating. The timing mattered as much as the duration. Walking immediately after the meal, while the gut was still absorbing glucose, produced a more effective glucose reduction than a longer walk taken later.

Earlier studies confirmed the same pattern in people with type 1 diabetes and in healthy adults, showing that post-meal walking reduces glucose excursions more meaningfully than pre-meal or fasted-state walking. The mechanism is relatively direct: muscle contraction during light movement increases glucose uptake by skeletal muscle through an insulin-independent pathway — GLUT4 transporter translocation — meaning blood sugar moves into cells whether or not insulin levels are high. This is particularly relevant for people whose insulin sensitivity is already declining, which describes most adults past their mid-thirties.

Over a year, over ten years, over two decades — smoothing those daily post-meal spikes is one of the most underrated things a person can do for their metabolic age.

What I do

Ten minutes, within thirty minutes of finishing a meal. No particular pace. No targets. I walk outside when I can; around the building when I can’t. After lunch is the highest-yield if someone only does it once a day — the post-lunch glucose response is often the largest of the three daily meals, and it hits during the hours when energy typically dips and people reach for coffee.

I tell patients: the meal ends, the walk begins. Not because you have time for it — make it the boundary. It takes the same time as checking your phone after eating. And it doubles as a stress reset, which is its own metabolic benefit.

3. I Track One Number So Aging Stops Being Invisible

Why this matters

Biological aging is quiet. It accumulates slowly, compounds for years, and rarely announces itself with a dramatic warning. Most of the patients I see with advanced metabolic dysfunction, elevated cardiovascular risk, or early chronic disease had normal labs five years earlier. Not because the labs were wrong — but because the labs they ran weren’t measuring what was actually moving.

The patients who change their trajectory share one behavior: they made aging visible. They picked one number that actually tracked their biological age — not their birthday — and they watched it move.

When aging is invisible, it is easy to postpone. When it has a value, it becomes a conversation you can have with yourself every three months.

What the research shows

hs-CRP (high-sensitivity C-reactive protein)

hs-CRP is a marker of systemic inflammation — the kind of sustained, low-grade inflammatory activity that damages blood vessels, impairs insulin signaling, accelerates cellular aging, and raises the risk of cardiovascular disease, diabetes, and all-cause mortality. A 2025 longitudinal cohort study in Archives of Gerontology and Geriatrics found that cumulative hs-CRP levels — even those below the traditional “elevated” threshold of 10 mg/L — were independently associated with increased all-cause mortality, mediated partly through blood pressure, fasting glucose, and uric acid. In other words, chronically elevated inflammation, even when it looks “normal” on a single lab draw, leaves a biological invoice.

The ACC/AHA guidelines identify hs-CRP ≥2.0 mg/L as a cardiovascular risk enhancer. In my practice, I watch trend lines, not single values. A patient whose hs-CRP was 0.8 two years ago and is now 1.7 is telling me something. They are not yet in “elevated” territory. They are moving toward it, and movement is the whole point.

ApoB (Apolipoprotein B)

ApoB is a better measure of cardiovascular aging risk than LDL cholesterol in most patients. Every atherogenic particle in the blood — including small dense LDL, IDL, and VLDL — carries exactly one ApoB molecule. Total ApoB therefore tells you how many atherogenic particles are circulating, not just their cholesterol content. Studies including the AMORIS study with more than 175,000 participants have shown ApoB to be a stronger predictor of fatal myocardial infarction than LDL-C. For a patient in their forties whose LDL looks acceptable but whose particle count is high, ApoB is the number that catches the risk that LDL misses.

Grip strength

This one surprises people.

Grip strength is one of the single most well-replicated predictors of all-cause mortality in medicine. A 2007 longitudinal study in The American Journal of Medicine followed nearly 5,000 adults for 30 years and found that grip strength in the highest quintile at baseline was associated with roughly half the mortality risk of those in the lowest quintile — a relationship that held for heart disease, stroke, and pneumonia, and remained significant after 20 years of follow-up. A 2022 meta-analysis of 121,116 adults across 29 countries confirmed the same dose-response relationship: every 5 kg increase in grip strength was associated with a 14% reduction in all-cause mortality and cardiovascular death.

What grip strength is measuring, indirectly, is the overall integrity of the neuromuscular system — the same system that governs balance, fall risk, recovery from illness, and the capacity to maintain independence into later life. It is not measuring hand strength alone. It is measuring how much biological reserve the entire system has.

You can measure it at home with a hand dynamometer for less than twenty dollars. You can recheck it every three months. It is more informative than most things on a standard annual panel.

What I do

I start patients on one number. Not four, not seven. One — the one that is most likely to be telling their particular story.

For someone with strong family history of cardiovascular disease or whose LDL looks acceptable but whose metabolic picture is unclear, I start with ApoB. For someone with vague fatigue, joint symptoms, or autoimmune risk, I start with hs-CRP. For someone whose primary concern is energy, blood sugar, and weight, I add fasting insulin alongside HbA1c — the two together reveal insulin resistance far earlier than HbA1c alone.

For patients who are skeptical about labs, I start with grip strength. Cheap. Immediate. Deeply predictive. Recheck it in 90 days. They always come back curious about the number.

Then we schedule. Every three to six months for labs. More often for home measures. Not obsessively — the goal is trend, not perfection. What gets measured tends to get managed. And what gets managed, over a decade, tends to matter.

A Word on What These Three Have in Common

None of these are glamorous. There is no device to buy, no subscription to start, and nothing to swallow.

They share a structural logic: they are all small signals sent to the body on a daily or weekly basis that remind it to stay capable of something. Balance practice tells the nervous system that proprioception and neuromuscular coordination still matter. Post-meal walking tells the metabolic system that it does not have to absorb glucose passively. Tracking a number tells the clinician — and the patient — that biological aging is being watched, not just assumed.

The patients who age well in my practice are not the ones doing the most. They are the ones doing the right things, consistently, before they needed to. Before the fall. Before the diagnosis. Before the number that was quietly moving finally made itself undeniable.

The goal was never just to add years. It was to make the years we add feel younger.

That is the real work of longevity medicine — and most of it still starts before breakfast.

Key Supporting Studies

Balance and fall prevention:

• Bergland A, et al. One-leg balance is an important predictor of injurious falls in older people. Age Ageing. 1997;26(2):123–130. [PMID: 9180669]pubmed.ncbi.nlm.nih

• Blodgett JM, et al. One-Legged Balance Performance and Fall Risk in Mid and Later Life. Am J Prev Med. 2023;64(3):e87–e95. [PMID: 36470757]sciencedirect+1

• Araújo CG, et al. Successful 10-second one-legged stance performance predicts survival in middle-aged and older individuals. Br J Sports Med. 2022;56(17):975–980.bjsm.bmj

• Cruz-Jentoft AJ, et al. Balance as an indicator of neuromuscular aging. Med News Today. 2024.medicalnewstoday

Post-meal walking and glucose:

• Shiraiwa T, et al. Positive impact of a 10-min walk immediately after glucose intake on postprandial glycemic control. Sci Rep. 2025;15:23161.nature+2

• Colberg SR, et al. The effect of walking on postprandial glycemic excursion in patients with type 1 diabetes. Diabetes Care. 2012. [PMID: 22875231]pubmed.ncbi.nlm.nih

hs-CRP and all-cause mortality:

• Tian Y, et al. Cumulative hs-CRP and all-cause mortality in middle-aged and elderly adults. Arch Gerontol Geriatr. 2025;135:105861. [PMID: 40354683]pubmed.ncbi.nlm.nih

• Blankenberg S, et al. Mortality risk prediction of high-sensitivity CRP. PMC8863282. 2022.pmc.ncbi.nlm.nih

ApoB and cardiovascular risk:

• Sniderman AD, et al. Age and Cardiovascular Risk Attributable to ApoB. Circulation. 2016. [PMC5121475]pmc.ncbi.nlm.nih

• Bonifacio E, et al. Significance of ApoB in elderly as predictive factor of cardio-cerebrovascular complications. Diabetes Res Clin Pract. 2009.sciencedirect

Grip strength and mortality:

• Sasaki H, et al. Grip strength predicts cause-specific mortality in middle-aged and elderly persons. Am J Med. 2007;120(4):337–342. [PMID: 17398228]pubmed.ncbi.nlm.nih

• López-Gil JF, et al. Longitudinal association of handgrip strength with all-cause and cardiovascular mortality. Exp Gerontol. 2022.sciencedirect

• del Pozo Cruz B, et al. Handgrip strength with all-cause and cancer mortality: 28 countries. Age Ageing. 2022;51(5):afac117. [PMID: 35639798]pubmed.ncbi.nlm.nih

• Taekema DG, et al. Prognostic value of handgrip strength in people 60+. Geriatr Gerontol Int. 2016. [PMID: 26016893]

About the Author

Dr. Shiv Kumar Goel, MD, is a internist and functional medicine physician in San Antonio, Texas. Trained at the Icahn School of Medicine at Mount Sinai, he is the founder of Prime Vitality Care and blends internal, functional, and integrative medicine to help patients align their health with their daily rhythms. He writes about longevity, stress physiology, and the reconnection of mind, body, and spirit in modern medicine.

She came in tired but matter-of-fact, the kind of fatigue you learn to carry without advertising. Mid‑forties, mid‑career banker, the sort of person whose life is built around other people’s anxieties about money. For three years, she had been waking up at 3:40 a.m. most nights—so consistently that she stopped needing the clock. It felt like her nervous system had set an alarm she hadn’t agreed to.

By the time she reached me, she had already done what most high-functioning patients do: supplements, devices, tracking. Melatonin. Magnesium. A sleek ring grading her sleep as if it were a quarterly report. The more she watched the numbers, the more anxious she became. Her scores dipped, and the story she told herself hardened: “I’m just a light sleeper. This is probably my age and my job catching up with me.”

On the surface, nothing was alarming. No major mood symptoms, no significant alcohol, no shift work. She went to bed around 10:30 p.m. She did “the right things” most sleep handouts mention. But when I asked her to walk me through the four hours before bed, not the five minutes before lights out, a different pattern appeared.

Dinner was often at 9 p.m., heavy and late, after a day of grazing and coffee. Lights in the kitchen and home office stayed bright and overhead long after dark, the kind of light that tells your brain it’s noon. The evening was full of unresolved tasks: emails half-drafted, deals half-closed, lists held silently in her head. Bedtime was not the end of the workday; it was where the workday got replayed.

I didn’t give her a new pill. Instead, we turned the focus to those four quiet hours before bed. We moved dinner earlier, aiming for at least a three‑hour window before she got under the covers—not as a rule to obey, but as an experiment in what happens when her body isn’t busy sorting out a late, heavy caloric load overnight. We lowered the angle and intensity of light: overheads off after sunset, warm lamps on, screens dimmed. And we created a small ritual for her mind: a handwritten list of unfinished tasks, followed by fiction that had nothing to do with banking, self‑improvement, or sleep.

Within a week, the 3:40 a.m. wake‑ups stopped. Not tapered, not “slightly better”—they simply didn’t show up. She still had stressful days. Markets still moved. But she no longer had the sense that her body was staging a nightly intervention. What changed wasn’t her diagnosis or her willpower; it was how food, light, and thought were arranged in the last part of the day.

Cases like hers keep pulling me back to a simple, unglamorous question: “Tell me about your evening.” Not the checklist of sleep hygiene tips, not the brand names of devices—but the lived, ordinary hours when your physiology is quietly deciding what kind of night you’re going to have. We talk a lot about insomnia as if it begins at bedtime. More often, it begins with the life that leads up to it

I think about her on the nights when my own patients tell me they’ve “tried everything” for their sleep. What they usually mean is that they’ve tried everything they can buy. The harder work is rearranging the hours that don’t look like medicine at all—the late dinner, the overhead light, the mental to‑do list we mistake for productivity. If your body keeps waking you at the same time night after night, it may not be punishing you; it may be pointing to the part of your day you’ve decided is non‑negotiable.

Healing the Split is a reader-supported publication. If you’d like more essays on sleep, stress physiology, and the stories patients tell themselves about being “high‑functioning” while exhausted, you can subscribe for free or choose a paid subscription to support the work. Paid readers help me carve out protected time for this kind of slow, narrative medicine—clinic stories that don’t fit in a 15‑minute visit or a lab report.

Subscribe now

Author bio

Dr Shiv Kumar Goel is a physician and functional medicine specialist based in San Antonio, Texas, who writes about the split between how people look on paper and how they actually feel. He practices at Prime Vitality Care and is the author of Healing the Split, a newsletter on symptoms, stories, and the quiet physiology of everyday life.